Germinoma of the Pituitary Gland; a Report of Two Cases
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Pediatric Suprasellar Germ Cell Tumors: a Clinical and Radiographic Review of Solitary Vs
cancers Article Pediatric Suprasellar Germ Cell Tumors: A Clinical and Radiographic Review of Solitary vs. Bifocal Tumors and Its Therapeutic Implications Darian R. Esfahani 1 , Tord Alden 1,2, Arthur DiPatri 1,2, Guifa Xi 1,2, Stewart Goldman 3 and Tadanori Tomita 1,2,* 1 Division of Pediatric Neurosurgery, Ann & Robert H. Lurie Children’s Hospital, Chicago, IL 60611, USA; [email protected] (D.R.E.); [email protected] (T.A.); [email protected] (A.D.); [email protected] (G.X.) 2 Department of Neurosurgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA 3 Division of Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation, Ann & Robert H. Lurie Children’s Hospital, Chicago, IL 60611, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-312-2274220 Received: 7 August 2020; Accepted: 10 September 2020; Published: 14 September 2020 Simple Summary: Bifocal suprasellar germ cell tumors are a unique type of an uncommon brain tumor in children. Compared to other germ cell tumors in the brain, bifocal tumors are poorly understood and have a bad prognosis. In this paper we explore features that predict which children will have good outcomes and which will not. This is important for the research community because it can help physicians decide what type of radiation treatment is best to treat these children. Our study shows that bifocal tumors have a unique appearance on magnetic resonance imaging (MRI) compared to other germ cell tumors. Children with bifocal tumors are more likely to be male, have tumors that come back sooner, and cause death sooner. -
Pineal Region Tumors: Computed Tomographic-Pathologic Spectrum
415 Pineal Region Tumors: Computed Tomographic-Pathologic Spectrum Nancy N. Futrell' While several computed tomographic (CT) studies of posterior third ventricular Anne G. Osborn' neoplasms have included descriptions of pineal tumors, few reports have concentrated Bruce D. Cheson 2 on these uncommon lesions. Some authors have asserted that the CT appearance of many pineal tumors is virtually pathognomonic. A series of nine biopsy-proved pineal gland and eight other presumed tumors is presented that illustrates their remarkable heterogeneity in both histopathologic and CT appearance. These tumors included germinomas, teratocarcinomas, hamartomas, and other varieties. They had variable margination, attenuation, calcification, and suprasellar extension. Germinomas have the best response to radiation therapy. Biopsy of pineal region tumors is now feasible and is recommended for treatment planning. Tumors of the pineal region account for less th an 2% of all intracrani al neoplasms [1]. While several reports of computed tomography (CT) of third ventricular neoplasms have in cluded an occasi onal pineal tumor [2 , 3], few have focused on the radiographic spectrum of th ese uncommon lesions [4]. Some authors have asserted that the CT appearance of many pineal tumors is virtuall y pathognomonic [5]. We studied a series of nine biopsy-proven pineal gland tumors that demonstrated remarkable heterogeneity in both histopath ologic and CT appearance. Materials and Methods A total of 17 pineal gland tumors were detected in 15,000 consecutive CT scans. Four patients were female and 13 were male. Mean age for the fe males was 27 years; for the males, 15 years. Initial symptoms ranged from headache, nausea, and vomiting, to Parinaud syndrome, vi sual field defects, diabetes insipidus, and hypopituitari sm (table 1). -
Clinical Radiation Oncology Review
Clinical Radiation Oncology Review Daniel M. Trifiletti University of Virginia Disclaimer: The following is meant to serve as a brief review of information in preparation for board examinations in Radiation Oncology and allow for an open-access, printable, updatable resource for trainees. Recommendations are briefly summarized, vary by institution, and there may be errors. NCCN guidelines are taken from 2014 and may be out-dated. This should be taken into consideration when reading. 1 Table of Contents 1) Pediatrics 6) Gastrointestinal a) Rhabdomyosarcoma a) Esophageal Cancer b) Ewings Sarcoma b) Gastric Cancer c) Wilms Tumor c) Pancreatic Cancer d) Neuroblastoma d) Hepatocellular Carcinoma e) Retinoblastoma e) Colorectal cancer f) Medulloblastoma f) Anal Cancer g) Epndymoma h) Germ cell, Non-Germ cell tumors, Pineal tumors 7) Genitourinary i) Craniopharyngioma a) Prostate Cancer j) Brainstem Glioma i) Low Risk Prostate Cancer & Brachytherapy ii) Intermediate/High Risk Prostate Cancer 2) Central Nervous System iii) Adjuvant/Salvage & Metastatic Prostate Cancer a) Low Grade Glioma b) Bladder Cancer b) High Grade Glioma c) Renal Cell Cancer c) Primary CNS lymphoma d) Urethral Cancer d) Meningioma e) Testicular Cancer e) Pituitary Tumor f) Penile Cancer 3) Head and Neck 8) Gynecologic a) Ocular Melanoma a) Cervical Cancer b) Nasopharyngeal Cancer b) Endometrial Cancer c) Paranasal Sinus Cancer c) Uterine Sarcoma d) Oral Cavity Cancer d) Vulvar Cancer e) Oropharyngeal Cancer e) Vaginal Cancer f) Salivary Gland Cancer f) Ovarian Cancer & Fallopian -
Germinoma of the Pineal Its Identity with Gcrminoma ( Scminoma") of the Testis
Germinoma of the Pineal Its Identity with Gcrminoma ( Scminoma") of the Testis Major Nathan B. Friedman, MC, AUS (From the Army Institute ot Pathology, \X/ashillgto~L D. C.) (Received for publication December 10, 1946) In 1944 Dorothy Russell (15) published the re- gcrminonmtous elements. Only 2 tulnors in this suits of a study of pineal tumors. She presented a group of 8 appeared to bc of neural origin; one, rational explanation for the well known similarity which had the pattern of a classic pinealoma, was in histologic appearance of "pinealomas" and "semi- TABLE l: DATA IN T\VENTY-THREt CASES OF PlNEAL nomas." She suggested that in'any "pincalomas" NEOPI.ASM ucre in truth teratoid tumors. The present report Case Age, Type of proposes to confirln h er.~obscrvations and to extend No. Sex years npoplasm s features her interpretations in accord with the teratologic CRovP 1 concepts gained through study of nearly 1,000 tu- 1 M 29 Neural mors of the testis at the Army Institute of Patho- 2 XI 22 Germinoma Extrapineal. Pitui- logy (6). tary involved. Dia- The files of the Institute contain pathologic ma- betes insipidus. Hypogonadism. terial from 23 patients with tumors of the pineal or ectopic "pinealomas." Fifteen tumors were submit- 3 1~i 17 Neural ted by military installations ~ (Group 1), and 8 were 4 1~I 18 Germinoma Pituitary involved. obtained from civilian sources e (Group 2). The Diabetes insipidus. _~I 21 essential data in all 23 cases arc listed in Table I. Puhnonary metas- tases. Radiosensi- Seven of the 15 tumors in group 1 were identical tMty. -
The Diagnosis and Pathological Value of Combined Detection of HE4 and CA125 for Patients with Ovarian Cancer
Open Med. 2016; 11:125-132 Research Article Open Access Li-e Zheng*, Jun-ying Qu, Fei He The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer DOI 10.1515/med-2016-0024 other. Conclusion HE4 can be used as a novel clinical bio- received January 28, 2016; accepted March 9, 2016 marker for predicting malignant ovarian tumors and its expression was closely related with the clinical pathologi- Abstract: Objective To evaluate the value of individual and cal features of malignant ovarian tumors. combined measurement of human epididymis protein 4 (HE4) and cancer antigen 125 (CA-125) in the diagnosis Keywords: HE4; CA125; diagnosis; ovarian tumor of ovarian cancer. Methods A clinical case-control study was performed in which the levels of serum HE4 and CA-125 of subjects with malignant, borderline, benign ovarian tumors and healthy women were measured before 1 Introduction surgery. An immunohistochemistry method was used In the female reproductive system, ovarian cancer ranks to measure the expression of HE4 in different tissues. third in incidence and 1st in mortality in gynecological Statistical analysis was performed to determine the rela- malignancies [1]. Nearly 70% of patients with ovarian tionship between the level of HE4 and the pathologic cancer are diagnosed at an advanced stage, and the 5 year type as well as the stage of the ovarian tumors. Results survival rate for patients with ovarian cancer rises up to The level of HE4 in the serum was significantly elevated in 90% through early effective treatment [2]. Hence, diag- the malignant ovarian cancer group compared with other nosing at early stage is crucial to improve the prognosis of groups. -
Non-Gestational Choriocarcinoma of the Ovary Complicated by Dysgerminoma: a Case Report
6 Case Report Page 1 of 6 Non-gestational choriocarcinoma of the ovary complicated by dysgerminoma: a case report Chi Zhang1,2,3, Yangmei Shen1,2 1Department of Pathology, West China Second University Hospital of Sichuan University, Chengdu, China; 2Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, China; 3The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, China Correspondence to: Yangmei Shen. Department of Pathology, West China Second University Hospital of Sichuan University, Chengdu 610041, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, China. Email: [email protected]. Abstract: To report a case of non-gestational ovarian choriocarcinoma complicated by dysgerminoma and summarize its clinical manifestations, pathological features, treatment, and prognosis. The clinical manifestations, histomorphological features, and immunohistochemical staining findings of a patient with choriocarcinoma complicated by dysgerminoma were recorded. Computed tomography and vaginal color Doppler ultrasound in the outpatient department of our hospital showed that there were large, cystic or solid masses in the pelvic and abdominal cavities, which were considered to be malignant tumors originating from adnexa. Extensive hemorrhage and necrosis were seen in tumor tissues, which were composed of two tumor components: one tumor component contained cytotrophoblasts and syncytiotrophoblasts, and had no placental villous tissue; the other tumor component consisted of medium-sized, round or polygonal cells. Germ cell tumors were considered based on the histological morphological features of the HE-stained slices. -
Genitourinary Advanced Pca and Its Efficacy As a Therapeutic Agent Is Presently Being Studied in Clinical Trials
ANNUAL MEETING ABSTRACTS 133A because they were over age 80 and as such, the IHC results were likely due to acquired 599 Anterior Predominant Prostate Tumors: A Contemporary methylation of the MLH1 promoter. The remaining 4 patients with absent staining have Look at Zone of Origin been referred to Cancer Genetics for possible further work-up. The reimbursement rate HA Al-Ahmadie, SK Tickoo, A Gopalan, S Olgac, VE Reuter, SW Fine. Memorial Sloan and turn-around time for the IHC stains were similar to that for other IHC stains used Kettering Cancer Center, NY, NY. in clinical practice. Background: Aggressive PSA screening and prostate needle biopsy protocols have Conclusions: IHC stains for the MMR proteins are fast and relatively easy to institute in successfully detected low-volume posterior tumors, with a concurrent increase in routine evaluation of CRC, and we have not had difficulty interpreting the stains leading anterior-predominant prostate cancer (AT). Zone of origin, patterns of spread, and to additional testing. Furthermore, reimbursement was obtained at a level similar to extraprostatic extension of these tumors have not been well studied. other IHC stains used in clinical practice. The surgeons and oncologists welcomed the Design: We greatly expanded and refined our previous studies to include pathologic prognostic information. Further study is warranted to confirm these initial findings. features of 197 patients with largest tumors anterior to the urethra in whole-mounted radical prostatectomy specimens. 597 High Fidelity Image Cytometry in Neoplastic Lesions in Barrett’s Results: Of 197 AT, 97 (49.2%) were predominantly located in the peripheral zone Esophagus, Including Basal Crypt Dysplasia-Like Atypia with Surface (PZ-D), 70 (35.5%) in the transition zone (TZ-D), 16 (8.1%) were of indeterminate Maturation zone (IND), and 14 (7.1%) in both PZ and TZ (PZ+TZ). -
Points of Consideration in Diagnosis of Brain Tumors
University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1934 Points of consideration in diagnosis of brain tumors Robert J. Stein University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Stein, Robert J., "Points of consideration in diagnosis of brain tumors" (1934). MD Theses. 356. https://digitalcommons.unmc.edu/mdtheses/356 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. POINTS OF CONSIDERATION IN DIAGNOSIS OF BRAIN TUMORS by Robert J. Stein University of Nebraska College of Medicine Omaha Page I. Introduction ••.••••••••••.••.••••••••••••••••••••••• 1. II. Histogenes is of the Brain ••••••••••••.•••••••••••••• I. III.Classification of Intracranial Tumors............ 11. IV. Outllne of Methods of Examination ••••••••••••••••••• 31. V. General Symutoms and Signs of Increased Intra- cran~al Pressure ••. ••• .••••••••••••••••••••• • • • :J •••• 36. VI. Focal Signs and Symptoms of Brain Tumor ••••••••••••• 45. Cerebral Tumors ••••••••••, •••••••••••••••••••••••••• 47. Tumors of Cerebellum, Pons and Medulla ••••••••••• •• 57. Tumors of the Pi tui tary Body ••••••••••••••••.•••• .'. 61. VI I. Summary. • • • • • • . • • • • • . • • • • • . • • • . • • • • • • • • . • . • • • • • • • •• 65. Bibliogranhy •••••••••••••••••••••••••• • • • • • • • • • • • • • 69. 1. I. INTRODUCTION The progress of the surgery of intracranial tumors has been asso ciated intimately wi th the advenae ment of asepsis and surgical technique in genera.l i methods of more accurate diagnosis and a correlation of the pathology of tumors encountered with the clini cal course of the patient. -
A Glioma in a Dog and a Pinealoma in a Silver Fox (Vulpes Fulvus)
A GLIOMA IN A DOG AND A PINEALOMA IN A SILVER FOX (VULPES FULVUS) CARL F. SCHLOTTHAUER, D.V.M., Division of E.aperinienta1 Medicine, The Mauo Foundation JAMES W. KERNOHAN, M.D., Section on Pathologic Anatomy, The Mayo Clinic, Rochester, Minnesota Only a small number of primary intracranial neoplasms have been observed in mammals and birds. Either they do not occur as fre- quently in lower animals as they do in man or they are overlooked. The latter is a probable explanation, as only a small number of animals that die of natural causes come to necropsy and because of the dif- ficulty of opening the cranium with inadequate equipment this part of the examination generally is omitted. Slye, Holmes and Wells, in 1931, reviewed the literature 011 intrn- cranial and cord tumors of lower animals and found only 36 cases re- ported. Twenty-six of these were intracraiiial tumors, 11 of which were in the hypophysis. They at that time reported 4 new cases of primary intracranial neoplasms, 3 occurring in mice of the Slye stock and one in a green parrakeet (Agatomis puEZuriu). The neoplasms found in tlie mice were : an endothelioma of a cerebral peduncle, a papil- lomatous growth in the ependyma of the lateral ventricle, and an in- filtrating adenoma of the hypophysis. The tumor observed in the parrakeet was an adeiioma in tlie hypophysis. Iii their summary thew writers mention that it is especially noteworthy that only one seemingly conclusive report of a cerebral glioma in an animal could be found. Dawes, in 1930, reported two intracrunial neoplasms in dogs. -
New Jersey State Cancer Registry List of Reportable Diseases and Conditions Effective Date March 10, 2011; Revised March 2019
New Jersey State Cancer Registry List of reportable diseases and conditions Effective date March 10, 2011; Revised March 2019 General Rules for Reportability (a) If a diagnosis includes any of the following words, every New Jersey health care facility, physician, dentist, other health care provider or independent clinical laboratory shall report the case to the Department in accordance with the provisions of N.J.A.C. 8:57A. Cancer; Carcinoma; Adenocarcinoma; Carcinoid tumor; Leukemia; Lymphoma; Malignant; and/or Sarcoma (b) Every New Jersey health care facility, physician, dentist, other health care provider or independent clinical laboratory shall report any case having a diagnosis listed at (g) below and which contains any of the following terms in the final diagnosis to the Department in accordance with the provisions of N.J.A.C. 8:57A. Apparent(ly); Appears; Compatible/Compatible with; Consistent with; Favors; Malignant appearing; Most likely; Presumed; Probable; Suspect(ed); Suspicious (for); and/or Typical (of) (c) Basal cell carcinomas and squamous cell carcinomas of the skin are NOT reportable, except when they are diagnosed in the labia, clitoris, vulva, prepuce, penis or scrotum. (d) Carcinoma in situ of the cervix and/or cervical squamous intraepithelial neoplasia III (CIN III) are NOT reportable. (e) Insofar as soft tissue tumors can arise in almost any body site, the primary site of the soft tissue tumor shall also be examined for any questionable neoplasm. NJSCR REPORTABILITY LIST – 2019 1 (f) If any uncertainty regarding the reporting of a particular case exists, the health care facility, physician, dentist, other health care provider or independent clinical laboratory shall contact the Department for guidance at (609) 633‐0500 or view information on the following website http://www.nj.gov/health/ces/njscr.shtml. -
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors Before Diagnosis: a Systematic Review
Review Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review Fatima Ghandour 1,2, Alessio Squassina 1, Racha Karaky 3, Mona Diab-Assaf 2, Paola Fadda 1,4,5,6,* and Claudia Pisanu 1 1 Department of Biomedical Sciences, Division of Neuroscience and Clinical pharmacology, University of Ca- gliari, 09042 Monserrato, Italy; [email protected] (F.G.); [email protected] (A.S.); [email protected] (C.P.) 2 EDST, Pharmacology and Cancerology Laboratory, Faculty of Sciences, Lebanese University, Beirut 1500, Lebanon; [email protected] 3 Drug-Related Sciences department, Faculty of Pharmacy, Lebanese University, Hadath 1500, Lebanon; [email protected] 4 Centre of Excellence "Neurobiology of Addiction", University of Cagliari, 09042 Monserrato, Italy 5 CNR Institute of Neuroscience - Cagliari, National Research Council, 09042 Monserrato, Italy 6 National Institute of Neuroscience (INN), 10126 Turin, Italy * Correspondence: [email protected] Table S1. Characteristics of “pediatric group” case reports (age < 18 years) with initial psychiatric symptoms with or without generalized and/or neurological signs and symptoms. Ref. Age Gender Tumor type Tumor location Psychiatric symptoms (P.S) Neurological symptoms Time from P.S after symptoms to tumor treat- diagnosis ment [1] 5 F Diffuse intrinsic Pontine Personality changes Motor deficits 3 weeks N.S. pontine glioma [2] 3 M Pilocytic Astrocyto- Rostral medulla Paroxysmal crying, anxiety Nausea, vomiting, seizure 8 months ✓ -
Ultrasound of Female Pelvic Organ
울산의대 서울아산병원 영상의학과 김미현 Introduction Benign disease of uterus Malignant disease of uterus Non-tumorous condition of ovary Tumorous condition of ovary Transvaginal – 소변(-) Transabdominal – 소변(+) Tranrectal or transperineal - virgin Sonohysterography Thick or irregular endometrium on transvaginal US Endometrium Basal layer – echogenic Functional layer – hypoechoic Endometrial stripe Endometrium 가임기 증식기 4-12 mm 분비기 8-15 mm 폐경기 5 mm 미만 Myometrium Innermost layer junctional zone Ovary Oval shape Central medulla – hyperecho Peripheral cortex (follicle) - hypoecho Benign disease of uterus Ectopic endometrial glands and stroma in the myometrium m/c cause of vaginal bleeding Due to unopposed estrogen Overgrowth of EM glands and stroma US Focally increased EM thickening DDx (HSG-US helpful) Hyperplasia Submucosal myoma < EM cancer m/c pelvic tumor Submucosal, intramural, subserosal US Well-defined hypoechoic solid mass Variable echogenicity due to degeneration Interface vessels btw tumor and uterus bridging vascular sign(+) Subserosal myoma > ovary tumor M U Cause Dilatation and currettage Gestational trophoblastic disease Complication of malignancy Previous surgery Uterine myoma Endometriosis Antagonist of the estrogen receptor in breast tissue Agonist in the endometrium EM hyperplasia Antagonist of the estrogen receptor in breast tissue Agonist in the endometrium EM hyperplasia Malignant disease of uterus Cervical cancer Endometrial cancer Gestational trophoblastic disease US- poor sensitivity for diagnosis • 45F, premenopause • EM